Clinical trial
Randomized Cross-over Trial in Patients Treated With Both Insulin & Hydrocortisone
NCT05716607 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Cross-over Trial in Patients Treated With Both Insulin & Hydrocortisone
- Lead sponsor
- Vastra Gotaland Region
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- January 1, 2025
- Completion date
- July 2, 2026
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adrenal insufficiency, diabetes mellitus, polyglandular autoimmune syndrome